Please Wait...

AAIC (Alzheimer's Association International Conference)

AAIC 2016
July 24, 2016 - 1:00am (EDT) to July 28, 2016 - 1:00am (EDT)

Toronto, Canada

Are you attending AAIC? If so, while there, network with Bioclinica representatives to learn more about our readily available global network of investigator sites and our leading medical imaging and molecular marker lab services.

Meet with Bioclinica to:

  • Discuss recruitment best practices for AD clinical trials.
  • Review optimal infrastructure required to conduct large prescreening programs and to execute protocols of prodromal Alzheimer's disease/mild cognitive impairment clinical trials.
  • Learn how Bioclinica CSF or blood-based biomarkers can advance your AD drug development program
  • Understand why Sponsors of critical Phase III AD studies with imaging endpoints overwhelmingly rely on Bioclinica's neuroscience team

Schedule a one-on-one with Bioclinica Alzheimer's Disease (AD) Key Opinion Leaders Joyce Suhy, PhD, Tanja Schubert, PhD, and Roger Bullock, MB.BS, MRCPsych here.

Bioclinica Posters at AAIC 2016

With more experience in the design and conduct of neuroimaging clinical trials than any other imaging core lab, Bioclinica's Neuroscience team will lead several poster sessions during this year's AAIC.

ASSESSING REGIONAL CORTICAL THICKNESS FOR PREDICTING MCI CONVERSION TO AD
Joel Schaerer, et al
Sat, Jul 23, 12:15 – 2:00 PM
Wed Jul 27, 12:00- 1:00 PM

Relationship between volumetric MRI parameters, APOE4 and MMSE status at baseline in Verubecestat (MK-8931) mild-to-moderate Alzheimer's disease patient trial
Cyrille Sur, et al
Mon Jul 25, 9:30-10:30 AM

Low Prevalence of Amyloid Positivity in Healthy Elderly Participants of a Methodology Study Evaluating Remote Tablet-Based Cognitive Learning
Claire Leurent, et al
Wed July 27, 9:30 – 10:30 AM

Does Regional Amyloid Burden Impact Domain-Specific Cognitive Impairment?
Tiffani Voss, et al
Wed July 27, 9:30 -10:30 AM

Head-to-Head Comparison of Image Analysis Methods in Longitudinal Alzheimer's disease FDG PET Studies
Gregory Klein, et al
Wed, July 27, 1:00 PM - 2:00 PM

Visit event website

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Come talk to #Bioclinica at #ASCO19! See why we're the world leader in #oncology imaging, helping to assess efficac… https://t.co/h0ng6StIbU
Bioclinica (7 hours ago)
Great insights for sponsors conducting #NAFLD #NASH #clinical trials. https://t.co/TG1WwRhVE8 https://t.co/US2Iobjoyd
Bioclinica (Yesterday)
Visit us at @DrugInfoAssn's DIA China to learn how Bioclinica's science & technology expertise can advance the deve… https://t.co/r4822CjVvv
Bioclinica (3 days ago)
Come talk to Bioclinica at #ASCO19! See why we're the world leader in #oncology imaging, helping to assess efficacy… https://t.co/MyomMS0Rvt
Bioclinica (6 days ago)
Great insights for sponsors conducting #NAFLD #NASH #clinicaltrials. https://t.co/TG1WwRhVE8
Bioclinica (1 week ago)
In Beijing for DIA China next week? If so, drop by Bioclinica's exhibit or catch our talk in the Randomization & Cl… https://t.co/LCNpNHabo2
Bioclinica (2 weeks ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box